(redirected from cholinergic receptor)
Also found in: Dictionary, Thesaurus, Medical, Encyclopedia.
Related to cholinergic receptor: adrenergic receptor, Nicotinic receptor
See: receiver
Mentioned in ?
References in periodicals archive ?
In conclusion, tiotropium, a long-acting cholinergic receptor antagonist, could significantly improve lung function, reduce the need for on-demand short-acting beta2-adrenoceptor agonists, and improve nocturnal symptoms in children with asthma.
We used Scop to promote amnesia in the animals because it has been shown to impair memory by blocking the muscarinic cholinergic receptors in the brain (Giovannini et al.
It can be concluded that hydroalcoholic extract of ginger has a relaxation effect on isolated trachea mostly via inhibition of cholinergic receptor and cholinergic system.
3]H]Propylbenzilylcholine mustard-labeling of muscarinic cholinergic receptors that selectively couple to phospholipase C or adenylate cyclase in two cultured cell lines.
Changes in cognition can result from cholinergic receptor manipulation or from cholinergically induced changes in vigilance or affective state.
It has been suggested that M2 muscarinic receptor subtype is the predominant cholinergic receptor on NTS membranes (9).
dioica, four groups of six SHR each were prepared for experimentation as outlined above but, autonomic ganglion (group 1), [alpha]-adrenoceptor (group 2), -[beta]adrenoceptor (group 3) and cholinergic receptor (group 4) blockades were produced by using a specific blocker (group 1: hexamethonium 20 mg/kg, group 2: phentolamine 2 mglkg, group 3: propranolol 0.
Scopolamine butylbromide is a synthetic, peripheral cholinergic receptor blocker that ameliorates the hyperreactivity of cholinergic receptors in the preganglionic sympathetic neurons and reduces the overcontraction of visceral smooth muscles.
Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: a review.
In this connection, Varenicline, a novel drug that acts as a partial agonist at the nicotinic cholinergic receptor holds particular importance in smoking cessation.
For this protocol, 15 min before last NA stimulation, we pre-incubated aorta rings with L-NAME (10 [micro]M, unspecific nitric oxide synthase inhibitor), indomethacin (10 [micro]M, unspecific COX inhibitor), ODQ (soluble guanylyl cyclase inhibitor), atropine (muscarinic cholinergic receptor antagonist) and TEA (unspecific potassium channel blocker) in according being the case.